{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:25:00Z","timestamp":1784053500843,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["A1-S-10749"],"award-info":[{"award-number":["A1-S-10749"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jsbmb.2021.105979","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T22:48:28Z","timestamp":1629758908000},"page":"105979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Antitumoral effects of dovitinib in triple-negative breast cancer are synergized by calcitriol in vivo and in vitro"],"prefix":"10.1016","volume":"214","author":[{"given":"Janice","family":"Garc\u00eda-Quiroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nohem\u00ed","family":"C\u00e1rdenas-Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Garc\u00eda-Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Morales-Guadarrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar A.","family":"M\u00e9ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-1598","authenticated-orcid":false,"given":"Clara","family":"Santos-Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo J.","family":"Ram\u00edrez-Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Segovia-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heriberto","family":"Prado-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euclides","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5947-4222","authenticated-orcid":false,"given":"Lorenza","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2021.105979_bib0005","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.2147\/OTT.S142154","article-title":"The crossroads of breast cancer progression: insights into the modulation of major signaling pathways","volume":"10","author":"Velloso","year":"2017","journal-title":"Onco. Ther."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0010","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12103029","article-title":"The FGF\/FGFR system in breast Cancer: oncogenic features and therapeutic perspectives","volume":"12","author":"Santolla","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12964-019-0486-4","article-title":"FGFR3 signaling and function in triple negative breast cancer","volume":"18","author":"Chew","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0025","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/2159-8290.CD-15-1246","article-title":"High-level clonal FGFR amplification and response to FGFR inhibition in a translational clinical trial","volume":"6","author":"Pearson","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0030","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/onc.2009.489","article-title":"Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets","volume":"29","author":"Turner","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113491","article-title":"Receptor tyrosine kinase-targeted Cancer therapy","volume":"19","author":"Yamaoka","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0040","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1038\/s41388-018-0380-3","article-title":"Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer","volume":"37","author":"Golfmann","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0045","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1158\/1078-0432.CCR-13-0190","article-title":"Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer","volume":"19","author":"Andre","year":"2013","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0050","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr3379","article-title":"Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models","volume":"15","author":"Issa","year":"2013","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13058-017-0807-8","article-title":"Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy","volume":"19","author":"Musolino","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4939-1789-1_16","article-title":"Receptor tyrosine kinases and drug resistance: development and characterization of in vitro models of resistance to RTK inhibitors","volume":"1233","author":"Corcoran","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0065","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1200\/JCO.2010.32.9458","article-title":"Fulminant acneiform eruptions after administration of dovitinib in a patient with renal cell carcinoma","volume":"29","author":"Hsiao","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2217\/fon.14.208","article-title":"Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity","volume":"11","author":"Porta","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0075","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41598-020-58438-0","article-title":"Identification of synergistic drug combinations using breast cancer patient-derived xenografts","volume":"10","author":"Turner","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0080","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.3390\/nu7065020","article-title":"Mechanistic effects of calcitriol in Cancer biology","volume":"7","author":"Diaz","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0085","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41419-020-02908-w","article-title":"1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells","volume":"11","author":"Jia","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0090","first-page":"5581","article-title":"Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptorpositive, human epidermal growth factor receptor 2positive breast cancer cells","volume":"17","author":"Lim","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0095","first-page":"337","article-title":"Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model","volume":"52","author":"Maj","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jsbmb.2014.12.006","article-title":"Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells","volume":"148","author":"Segovia-Mendoza","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0105","first-page":"1486","article-title":"The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells","volume":"7","author":"Segovia-Mendoza","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0110","doi-asserted-by":"crossref","first-page":"645","DOI":"10.12669\/pjms.333.11753","article-title":"Association between vitamin d deficiency and breast Cancer","volume":"33","author":"Shaukat","year":"2017","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111739","article-title":"Synergistic antitumorigenic activity of calcitriol with curcumin or resveratrol is mediated by angiogenesis inhibition in triple negative breast Cancer xenografts","volume":"11","author":"Garcia-Quiroz","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0120","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00432-013-1476-3","article-title":"Doxorubicin induces atypical NF-kappaB activation through c-Abl kinase activity in breast cancer cells","volume":"139","author":"Esparza-Lopez","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-016-0298-4","article-title":"Calcitriol stimulates gene expression of cathelicidin antimicrobial peptide in breast cancer cells with different phenotype","volume":"23","author":"Garcia-Quiroz","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0130","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0140","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0145","first-page":"925","article-title":"The mass-action law based algorithm for cost-effective approach for cancer drug discovery and development","volume":"1","author":"Chou","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0155","article-title":"Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol","volume":"9","author":"Crowe","year":"2019","journal-title":"Bio Protoc"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0160","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/cdd.2008.47","article-title":"Death through a tragedy: mitotic catastrophe","volume":"15","author":"Vakifahmetoglu","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/01913123.2010.543753","article-title":"Mitotic catastrophe in malignant epithelial tumors: the pathologist\u2019s viewpoint","volume":"35","author":"Caruso","year":"2011","journal-title":"Ultrastruct. Pathol."},{"issue":"Pt A","key":"10.1016\/j.jsbmb.2021.105979_bib0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jsbmb.2013.09.019","article-title":"Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis","volume":"144","author":"Garcia-Quiroz","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2012.09.004","article-title":"1,25(OH)(2)vitamin D(3) enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C(2)C(12) skeletal muscle cells","volume":"133","author":"Garcia","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsbmb.2017.10.013","article-title":"Calcitriol promotes proangiogenic molecules in keratinocytes in a diabetic foot ulcer model","volume":"174","author":"Trujillo","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cmet.2014.05.022","article-title":"Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal","volume":"20","author":"Sounni","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102176","article-title":"The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRalpha, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer","volume":"9","author":"Jansson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0195","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/07391102.2018.1433067","article-title":"Exploring the binding interaction of calf thymus DNA with lapatinib, a tyrosine kinase inhibitor: multi-spectroscopic techniques combined with molecular docking","volume":"37","author":"Chen","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0200","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bcp.2012.09.023","article-title":"The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II","volume":"84","author":"Hasinoff","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0205","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/acs.jmedchem.9b00726","article-title":"Dual inhibitors of human DNA topoisomerase II and other cancer-related targets","volume":"63","author":"Skok","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0210","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.bjp.0702103","article-title":"EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro","volume":"125","author":"James","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0215","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-16-0095","article-title":"Vitamin d enhances the efficacy of irinotecan through miR-627-Mediated inhibition of intratumoral drug metabolism","volume":"15","author":"Sun","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/jcmm.12176","article-title":"Dovitinib induces mitotic defects and activates the G2 DNA damage checkpoint","volume":"18","author":"Man","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0225","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ijrobp.2010.01.028","article-title":"The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity","volume":"77","author":"Krueger","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-018-0443-3","article-title":"Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes","volume":"25","author":"Lee","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.RES.87.3.214","article-title":"1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo","volume":"87","author":"Mantell","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0240","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.yexcr.2009.11.008","article-title":"Calcitriol inhibits Ether-a go-go potassium channel expression and cell proliferation in human breast cancer cells","volume":"316","author":"Garcia-Becerra","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0245","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1158\/1078-0432.CCR-06-1165","article-title":"A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors","volume":"13","author":"Fakih","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.jsbmb.2021.105979_bib0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00280-009-1000-2","article-title":"A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors","volume":"65","author":"Muindi","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0255","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1078-1439(03)00170-4","article-title":"Development of weekly high-dose calcitriol based therapy for prostate cancer","volume":"21","author":"Beer","year":"2003","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.jsbmb.2021.105979_bib0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/0091270011433330","article-title":"Population pharmacokinetic\/pharmacodynamic modeling to assist dosing schedule selection for dovitinib","volume":"53","author":"Wang","year":"2013","journal-title":"J. Clin. Pharmacol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076021001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076021001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:08:10Z","timestamp":1760746090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076021001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":52,"alternative-id":["S0960076021001722"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105979","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202102.0063.v1","asserted-by":"object"}]},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumoral effects of dovitinib in triple-negative breast cancer are synergized by calcitriol in vivo and in vitro","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105979"}}